post solid result pharmaci usa drive strong top line
pressur retail challeng persist view growth initi
expans digit platform encourag gain steam addit
announc complet store purchas
nr cash flow remain solid continu view risk/reward
balanc maintain hold pt ep
rite-aid complet morn announc compani
complet acquisit store sinc quarter end
although manag expect materi accret rite aid
store integr underway track conclud
previous commun integr process
take time remain upbeat deal tie increment scale
complementari geograph footprint synergi benefit
post net revenu come ahead
consensu tie strong pharmaci usa rev/script currenc
benefit across divis script volum ss
touch shi estim despit solid contribut
strateg partnership better expect rev/script drove
beat tie increas volum specialti alliancerx ventur
continu market share gain highest ever strong
pharmaci perform partial off-set on-going weak retail
side sale ss margin segment grew
improv merchandis product mix health beauti store
brand gain traction oper margin came bp
primarili tie better expect contribut beat
flow bottom line augment tax reform result
adj ep vs strhe
detail guidan rais cffo
came estim tie larg
time work capit addit compani rais full year
guidanc tie
substanti tax benefit origin anticip vs prior
estim rais rais estim reflect result
revis tax guidanc rais adjust ep
estim
tr target
lot initi drive growth
part strateg initi improv oper effici compani invest
date expect spend addit next year build new
platforms/system data collect analysi compani user balanc
reward program util resourc market data/custom insight
addit continu make progress enhanc beauti offer roll
extend store initi result encourag beauti differenti store
gener retail margin averag higher store without offer compani also
launch new pilot store build beauti offer well add optic care lab
servic view opportun drive pharmaci retail foot traffic lastli
remain focus expand digit presenc initi channel shown encourag result
app download time retail script renew use digit channel
 yoy
pharmaceut wholesal divis post revenu come ahead
estim ss growth came cc bit shi growth target challeng
market condit europ off-set strong result emerg market
retail pharmaci intern revenu came ahead estim primarili
favor currenc translat sale constant currenc basi overal ss sale
fell cc cc increas ss pharmaci sale boot uk cc off-set
cc declin ss retail sale driven on-going challeng boot uk cc
oper environ remain difficult strong cost manag off-set much top
line weak expand margin bp drive cc increas yoy adjust oper
page
revenu
revenu
revenu
net incom
non-gaap add back tax
adjust net incom
page
inc global leader pharmaceut servic industri
store prior pend deal sizabl wholesale/distribut network countri
compani largest retail pharmaci unit state retail pharmaci usa divis
gener total compani revenu remain sale come
retail intern pharmaci revenu wholesal revenu
bullish underli trend pharmaceut servic expect sever tailwind
age popul util growth increas gener penetr growth specialti drive on-going
growth sector forese futur believ recent format sever strateg
partnership optum prime tricar demonstr valu compani scale/cap
provid near term volum tailwind reason optim challeng exist
 retail pharmaci busi continu see margin pressur tie sever factor
rate price pressur payer contract increasingli difficult overal retail environ
valuat risk
hold rate price target base stock trade adjust cash
ep slight discount current multipl upbeat underli trend
pharmaceut servic view compani scale key differenti upbeat
deal like compani free cash flow gener view risk/reward balanc given us
pharmaci margin pressur like linger difficult retail environ upsid risk
price target includ better synergi captur stronger core trend dissip pbm margin pressur
aggress capit deploy downsid risk includ issu integr increas
price pressur addit retail competit
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
